Related Experiment Videos
[Pulmonary complications after bone marrow transplantation]
H Teschler1, K Quabeck, U W Schäfer
1Ruhrlandklinik, Abt. Allergologie und Pneumologie-Universitätsklinik.
Pneumologie (Stuttgart, Germany)
|February 1, 1994
Summary
Pulmonary complications are a significant risk after bone marrow transplantation (BMT), caused by immunosuppression and graft-versus-host disease. Early diagnosis and targeted treatments, alongside preventative strategies, are crucial for improving patient outcomes.
Area of Science:
- Hematology
- Pulmonology
- Oncology
Context:
- Bone marrow transplantation (BMT) is a critical treatment for various hematologic and oncologic conditions.
- Patients undergoing BMT face significant risks of pulmonary complications, contributing to morbidity and mortality.
- These complications arise from immunosuppression and graft-versus-host disease (GVHD) post-transplant.
Purpose:
- To review the spectrum, causes, diagnosis, and management of pulmonary complications following BMT.
- To highlight the importance of early and accurate diagnosis for effective treatment.
- To discuss current and emerging strategies for preventing pulmonary complications in BMT recipients.
Summary:
- Pulmonary complications in BMT patients encompass a range of early and late-onset lung and airway diseases.
- Key contributing factors include iatrogenic immunosuppression (chemotherapy, irradiation) and graft-versus-host disease (GVHD).
- Diagnostic tools like chest roentgenogram, bronchoscopy, and bronchoalveolar lavage are essential for prompt identification and treatment.
Impact:
- Early and specific treatment of pulmonary complications can significantly improve patient outcomes.
- Preventative measures, including optimized conditioning, immune reconstitution, prophylactic therapies, and GVHD modification, are vital.
- Advances in BMT care aim to reduce the incidence and severity of pulmonary sequelae, enhancing survival rates.